BTG plc (LON:BTG – Get Free Report) shares crossed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of GBX 840 ($10.63) and traded as high as GBX 840 ($10.63). BTG shares last traded at GBX 840 ($10.63), with a volume of 271,742 shares traded.
BTG Stock Up 0.1 %
The company’s fifty day moving average price is GBX 840 and its 200 day moving average price is GBX 840. The company has a market capitalization of £3.26 billion and a P/E ratio of 29.47.
About BTG
BTG plc acquires, develops, manufactures, and commercializes pharmaceutical products in the United States, Europe, and internationally. It operates through three segments: Interventional Medicine, Pharmaceuticals, and Licensing. The Interventional Medicine segment offers interventional oncology products and systems, such as beads and TheraSphere for treatment of liver cancer; and GALIL medical system, a cryoablation technology for use in kidney cancer and other indications.
Recommended Stories
- Five stocks we like better than BTG
- Canadian Penny Stocks: Can They Make You Rich?
- You Can Follow BlackRock’s Market View for Your Money
- How to Invest in the Best Canadian Stocks
- Breakout Alert: Coinbase’s Consolidation Is About To End
- What Percentage Gainers Tell Investors and Why They Don’t Tell the Whole Story
- 3 Key Stocks Helping to Drive the EV Race
Receive News & Ratings for BTG Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BTG and related companies with MarketBeat.com's FREE daily email newsletter.
